BC Week In Review | May 17, 2017
Clinical News

Santalis starts Phase II of East Indian Sandalwood Oil for atopic dermatitis

The Santalis Pharmaceuticals Inc. subsidiary of Quintis Ltd. (ASX:QIN) began a Phase II trial evaluating twice-daily 5% East Indian Sandalwood Oil cream (EISO, SAN007) for 28 days to treat mild to moderate atopic dermatitis. The...
Items per page:
1 - 1 of 1